Clinical trial
Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine
NCT00167739 · Albert Schweitzer Hospital, Other · Completed
Key facts
| NCT number | NCT00167739 |
|---|---|
| Title | Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine |
| Official title | Short Course of Quinine Plus a Single Dose of Sulphadoxine-Pyrimethamine for Plasmodium Falciparum Malaria |
| Lead sponsor | Albert Schweitzer Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Quinine plus sulfadoxine-pyrimethamine |
| Enrollment | 50 |
| Start date | Apr 1, 2003 |
| Completion | Feb 1, 2004 |
| First posted | Sep 14, 2005 |
| Last update posted | Sep 21, 2005 |
| Countries | Gabon |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: